News
02-04-2018, 10:43 PM
In recent years, a powerful suite of drugs known as kinase inhibitors have been developed to treat cancer and other diseases. Primary targets of such drugs include a family of receptor tyrosine kinases (RTKs) which protrude from cell surfaces like antennae and can activate cancer-related pathways in virtually all types of cancer when signaling molecules bind with them.
More... (https://www.news-medical.net/news/20180205/Researchers-use-innovative-method-to-screen-kinases-for-cancer-drugs-effectiveness.aspx)
More... (https://www.news-medical.net/news/20180205/Researchers-use-innovative-method-to-screen-kinases-for-cancer-drugs-effectiveness.aspx)